GlassScriptPhysician profile
Tyler David Christy
NPI 1689094971
$716.13
in general payments reported to CMS, 2019-2025
16 companies · $620 in 2025
The $620 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.85 · 2024: $75.09 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $170.69 | 2024-2025 | |
| Dexcom, INC. | $111.08 | 2024-2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $103.23 | 2024-2025 | Aptima |
| Indivior INC. | $46.69 | 2025 | Sublocade |
| Viiv Healthcare Company | $44.57 | 2024-2025 | Apretude |
| Redhill Biopharma INC. | $28.94 | 2025 | Talicia |
| Novo Nordisk INC | $26.83 | 2025 | |
| Edwards Lifesciences Corporation | $23.01 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lilly USA, LLC | $21.66 | 2025 | Mounjaro, Zepbound |
| Pfizer INC. | $20.85 | 2023 | |
| Dynavax Technologies Corporation | $20.58 | 2025 | Heplisav-B |
| Glaxosmithkline, LLC. | $20.30 | 2025 | Bexsero |
| Braeburn INC. | $20.16 | 2025 | Brixadi |
| Exact Sciences Corporation | $19.74 | 2025 | Cologuard Collection Kit |
| Seqirus USA INC | $18.94 | 2025 | Flucelvax, Fluad |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.86 | 2025 | Capvaxive, Gardasil 9, Vaxneuvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Christy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.